SCHEMBL22191264

SCHEMBL22191264

O=c1[nH]c2ccc(-c3cnc(NCc4cccc5ccccc45)nc3)cc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.48
▸ PIK3CB P42338 5/20 0.47
▸ PIK3CA P42336 4/20 0.47
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HDAC3 O15379 1/20 0.44
▸ MAPT P10636 3/20 0.44
▸ GAA P10253 2/20 0.44
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ PLK4 O00444 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ LYN P07948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29437806 1.00 DYRK1A (0.48) DYRK1APIK3CBPIK3CACYP3A4CYP2C9
SCHEMBL22191387 0.89 MAPT (0.54) DYRK1APIK3CBPIK3CACYP3A4CYP2C9
SCHEMBL22190920 0.84 GAA (0.64) DYRK1ACYP2C9MAPTGAAMEN1
SCHEMBL22190817 0.84 GAA (0.54) DYRK1AHDAC3MAPTGAAMEN1
SCHEMBL22191663 0.84 GAA (0.46) DYRK1APIK3CBPIK3CACYP3A4CYP2C9
SCHEMBL22191275 0.83 GAA (0.48) DYRK1APIK3CBPIK3CACYP3A4CYP2C9
SCHEMBL22191095 0.82 PLK4 (0.50) DYRK1AHDAC3MAPTGAAKMT2A
SCHEMBL22191518 0.81 PDE3B (0.45) GAAMEN1KMT2APLK4CHEK1
SCHEMBL29664534 0.81 PIK3CB (0.46) DYRK1APIK3CBPIK3CACYP3A4CYP2C9
SCHEMBL29437817 0.80 MKNK2 (0.44) DYRK1AHDAC3MAPTGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3906028-A1 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE Icahn School of Medicine at Mount Sinai (US) 2021-11-10 — — EP disclosed
CN-113543783-A Kinase inhibitor compounds and compositions and methods of use 西奈山伊坎医学院 2021-10-22 — — CN disclosed
WO-2020142486-A1 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2020-07-09 — — WO disclosed
Send feedback